EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY 4.0

Characterization of RufT Thioesterase Domain Reveals Insights into Rufomycin Cyclization and the Biosynthetic Origin of Rufomyazine

Yaoyu Ding iD, Gustavo Perez-Ortiz, Alexandra-Georgiana Butulan iD, Hamzah Sharif, Sarah M Barry iD

ACS Chemical Biology · 2025

DOI: 10.1021/acschembio.4c00802 ↗

Kurz gefasst

Leserbrief in der Zeitschrift ACS Chemical Biology, 2025. Verfasst von Yaoyu Ding und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Natural, Mathematical and Engineering Sciences, King's College London, Britannia House, 7 Trinity Street, London …. Hauptthemen laut MEDLINE: Streptomyces, Peptides, Cyclic. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King's College London, Medical Research Council, Royal Society of Chemistry.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nonribosomal cyclic peptides (NRcPs) rufomycins, produced by Streptomyces atratus, have attracted attention as antimycobacterials. Thus, there has been interest in engineering the corresponding biosynthetic pathway to produce novel derivatives. We have thus investigated the type I thioesterase (TE) of the NRPS RufT that catalyzes rufomycin peptide macrocyclization to understand its tolerance to changes in substrate peptide sequence. In contrast to our previously reported efficient cyclization chemistry, the recombinant RufT-TE domain and RufT-PCP-TE didomain, while tolerating some substrate structural changes, both produce high levels of hydrolyzed peptide. Closer analysis led to the identification of the natural product diketopiperazine rufomyazine in assays. The data indicate, with significant implications for rufomycin production, that RufT produces both cyclic and linear peptides. We propose that rufomyazine forms non-enzymatically from the linear peptide. In addition, it provides evidence for TE domains as gatekeepers in NRPS biosynthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

StreptomycesPeptides, CyclicCyclizationThiolester HydrolasesDiketopiperazinesProtein DomainsPeptide SynthasesBacterial Proteins

Substanzen

Peptides, CyclicThiolester HydrolasesDiketopiperazinesPeptide SynthasesBacterial Proteins

Autor:innen und Institutionen

  • Department of Chemistry, Faculty of Natural, Mathematical and Engineering Sciences, King's College London, Britannia House, 7 Trinity Street, London SE1 1DB, U.K.

ORCID-Profile: Yaoyu Ding, Alexandra-Georgiana Butulan, Sarah M Barry

Förderung

  • King's College London
  • Medical Research Council
  • Royal Society of Chemistry
  • Consejo Nacional de Humanidades, Ciencias y Tecnolog?as
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Ding, Y., Perez-Ortiz, G., Butulan, A. G., Sharif, H., & Barry, S. M. (2025). Characterization of RufT Thioesterase Domain Reveals Insights into Rufomycin Cyclization and the Biosynthetic Origin of Rufomyazine. ACS Chemical Biology. https://doi.org/10.1021/acschembio.4c00802

Vancouver

Ding Y, Perez-Ortiz G, Butulan AG, Sharif H, Barry SM. Characterization of RufT Thioesterase Domain Reveals Insights into Rufomycin Cyclization and the Biosynthetic Origin of Rufomyazine. ACS Chemical Biology. 2025. doi:10.1021/acschembio.4c00802

BibTeX
@article{Ding2025,
  author = {Ding, Yaoyu and Perez-Ortiz, Gustavo and Butulan, Alexandra-Georgiana and Sharif, Hamzah and Barry, Sarah M},
  title = {Characterization of RufT Thioesterase Domain Reveals Insights into Rufomycin Cyclization and the Biosynthetic Origin of Rufomyazine},
  journal = {ACS Chemical Biology},
  year = {2025},
  doi = {10.1021/acschembio.4c00802}
}
Kostenlos starten →